Select therapeutic use:
Indications for TUDORZA PRESSAIR:
Long-term, maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
400mcg twice daily.
Milk protein sensitivity.
Not for initial treatment of acute episodes of bronchospasm. Narrow-angle glaucoma. Urinary retention. Discontinue immediately if hypersensitivity reactions occur; consider alternative therapy. Labor & delivery. Pregnancy (Cat.C). Nursing mothers.
Avoid concomitant anticholinergic agents.
Headache, nasopharyngitis, cough, diarrhea, sinusitis; paradoxical bronchospasm.
Dry powder inhaler—60 doses